Showing results (471-480 of 918) with videos related to
Sort By:
Pageof 92
Current Drug Targets|February 6, 2015
Bladder cancer: molecular determinants of personalized therapyAntonio Lopez-Beltran, Matteo Santoni, Francesco Massari, et al.Nature Communications|October 21, 2022
A phase II trial of weekly nab-paclitaxel for progressive and symptomatic desmoid tumorsJavier Martin-Broto, Andres Redondo, David S Moura, et al.Cancer Treatment Reviews|June 11, 2018
Adjuvant and neoadjuvant approaches for urothelial cancer: Updated indications and controversiesFrancesco Massari, Matteo Santoni, Vincenzo di Nunno, et al.Drugs in Context|June 15, 2018
Immunotherapy in renal cell carcinoma: latest evidence and clinical implicationsMatteo Santoni, Francesco Massari, Vincenzo Di Nunno, et al.Critical Reviews in Oncogenesis|April 2, 2018
Liquid Biopsies in the Management of Bladder Cancer: Next-Generation Biomarkers for Diagnosis, Surveillance, and Treatment-Response PredictionYu Yang, Catherine R Miller, Antonio Lopez-Beltran, et al.Animal Reproduction|July 2, 2025
Effects of cactus (Opuntia ficus-indica) mucilage on boar sperm cryosurvivalJuan Antonio Ramírez-Chequer, Marco Antonio Lopez-Carlos, Carlos Fernando Arechiga-Flores, et al.Current Drug Targets|February 23, 2016
Emerging Immunotargets and Immunotherapies in Prostate CancerRodolfo Montironi, Matteo Santoni, Valeria Sotte, et al.Optics Letters|June 1, 2016
Visible supercontinuum generation in a graded index multimode fiber pumped at 1064 nmG Lopez-Galmiche, Z Sanjabi Eznaveh, M A Eftekhar, et al.Virchows Archiv : an International Journal of Pathology|October 8, 2019
Digital versus light microscopy assessment of extraprostatic extension in radical prostatectomy samplesMetka Volavšek, Vanessa Henriques, Ana Blanca, et al.European Urology|May 27, 2014
Understanding pathologic variants of renal cell carcinoma: distilling therapeutic opportunities from biologic complexityBrian Shuch, Ali Amin, Andrew J Armstrong, et al.Pageof 92